Clinical trial

ACP-204 in Adults With Alzheimer's Disease Psychosis

NCT06159673

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention ACP-204 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

ACP-204 in Adults With Alzheimer's Disease Psychosis

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-11-14

PhasePHASE2 / PHASE3

Conditions

Alzheimer's Disease Psychosisunresolved

Interventions

ACP-204DRUG

PlaceboDRUG

Sponsors & collaborators

ACADIA Pharmaceuticals Inc.lead sponsor

Mapped research locations

MiamiFlorida, United States9 SeoulSouth Korea6 SofiaBulgaria6 HoustonTexas, United States5 BelgradeSerbia5 São PauloBrazil4 PragueCzechia3 RomaItaly3 SantiagoChile3 ParisFrance2 ToulouseFrance2 Kaohsiung CityTaiwan2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06159673 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.